MIAMI & MEMPHIS, Tenn.--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) and Immuno Technologies, Inc. today announced that the National Institutes of Health (NIH) has awarded a $3 million grant to develop a rapid diagnostic test for Lyme disease. The Phase II Small Business Innovation Research (SBIR) grant was issued to Immuno Technologies working in collaboration with OPKO Diagnostics, LLC and Columbia University in the City of New York. The goal of the grant is to develop a rapid diagnostic tes
| < Prev | Next > |
|---|
